Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2013
11/27/2013EP2666856A1 Composition for inhibiting target gene expression
11/27/2013EP2666466A1 Process for production of nk-cell-enriched blood preparation
11/27/2013EP2665816A1 Biologically active nucleotide molecules for selectively killing off cells, use thereof, and application kit
11/27/2013EP2665752A1 Compositions for regulating iron homeostasis and methods of using same
11/27/2013EP2665730A1 Compounds with super-aspirin effects
11/27/2013EP2665727A1 Bicyclic carboxamide inhibitors of kinases
11/27/2013EP2665725A1 Bicyclic inhibitors of alk
11/27/2013EP2665724A1 Bicyclic inhibitors of alk
11/27/2013EP2665712A1 Quinazolinone inhibitors of dynein
11/27/2013EP2665711A1 Picolinamide inhibitors of kinases
11/27/2013EP2665706A1 Novel 4-amino-n-hydroxy-benzamides as hdac inhibitors for the treatment of cancer
11/27/2013EP2665521A2 Compositions and methods for treating cancer
11/27/2013EP2665491A1 Kit for the localized activation of high concentrations of a drug and the procedure thereof
11/27/2013EP2665489A1 Combination therapy for cancer
11/27/2013EP2665486A1 Compositions and mehthods for modulating gamma-c-cytokine activity
11/27/2013CN103415534A Antigen presenting cell targeted cancer vaccines
11/27/2013CN103415525A Bromodomain inhibitors and uses thereof
11/27/2013CN103415518A Imidazopyrazines for use as MPS-1 and TKK inhibitors in the treatment hyperproliferative disorders
11/27/2013CN103415516A Bicyclic inhibitors of ALK
11/27/2013CN103415303A Carboxylic mannan-coated contrast agent for magnetic resonance imaging
11/27/2013CN103409435A Preparation and application of water stress protein gene of nostoc commune and recombinant proteins of gene
11/27/2013CN103409428A Aptamer and application in preparing medicine or product for treating leukaemia thereof
11/27/2013CN103409323A Gynostemma endophytic fungi and application thereof
11/27/2013CN103408708A Preparation method of near-infrared light response hydrogel
11/27/2013CN103408677A Periodate-oxidized heparan sulfate for inhibiting cell proliferation
11/27/2013CN103408676A Nadroparin calcium preparation technology
11/27/2013CN103408666A Humanized anti-AEG-1 single chain antibody and application thereof
11/27/2013CN103408665A N-substituted tetrahydropyridine connected-5-substitured indole-monoclonal antibody CD33 conjugate and CD34 conjugate and preparation methods and application thereof
11/27/2013CN103408654A rTRAIL (TNT Related Apoptosis-Inducing Ligand) mutant-mPEG-MAL conjugate and application thereof
11/27/2013CN103408652A Novel anti-HBV endogenous protein HNF1alpha and application thereof
11/27/2013CN103408650A Cereus sinensis verrill soluble cell peptide CCT-I and separating and purifying method and application thereof
11/27/2013CN103408606A N-(2-deoxy-lactose-2-group)-3-(substituted phenyl) acrylamide and medical application thereof
11/27/2013CN103408597A Aromatic ruthenium complex and synthetic method thereof
11/27/2013CN103408573A Boric acid derivatives, and preparation method and application thereof
11/27/2013CN103408572A Chiral amino boric acid derivatives, and preparation method and application thereof
11/27/2013CN103408546A 2-phenylaminopurine PLK1 (Polo-like kinase 1) inhibitors and applications thereof
11/27/2013CN103408541A Indole-substituted thiazolo cyclohexane compound and antineoplastic applications thereof
11/27/2013CN103408540A 2-imidazole ring-substituted thiophene PLK1 (Polo-like kinase 1) inhibitors and applications thereof
11/27/2013CN103408537A 5-substituted dihydrobenzofuran-imidazolium salt compound and preparation method thereof
11/27/2013CN103408530A Coumarin skeleton polycyclic compound with biological activity as well as preparation method and use thereof
11/27/2013CN103408528A Chroman compound, as well as preparation method and application thereof
11/27/2013CN103408477A Arsenic coordination compound and preparation method thereof
11/27/2013CN103405791A Graphene oxide/BaGdF5/PEG multifunctional material as well as preparation method and application thereof
11/27/2013CN103405786A Application of antisense oligonucleotides sequence of NSMCE2 (Non SMC Element 2) in preparation of medicine for inhibiting growth of colorectal cancer cell
11/27/2013CN103405785A Use of gene GADD45 beta in preparation of drug for treating bladder cancer
11/27/2013CN103405784A Use of c-Fos gene in preparation of anti-cancer drugs
11/27/2013CN103405783A OX26/CTX-PL/pC27 compound and application of OX26/CTX-PL/pC27 compound in treating gliomas
11/27/2013CN103405778A Colon-targeted pro-drug based on nanometer cellulose carrier and preparation method of colon-targeted pro-drug
11/27/2013CN103405770A Application of CDK2 antagonist as differentiation therapy drug sensitizer
11/27/2013CN103405769A Application of photosensitizer to preparation of virus inactivated medicines for treating diseases
11/27/2013CN103405759A Method for preparing tumor-specific DC vaccine by applying CD34+ cells of umbilical cord blood
11/27/2013CN103405758A Method for preparing tumor-specific DC vaccine by applying mononuclear cells in umbilical cord blood
11/27/2013CN103405752A Oral thymosin alpha1 solid lipid nanoparticle absorption preparation and preparing method thereof
11/27/2013CN103405751A Composition with cell repairing function and preparation method and application thereof
11/27/2013CN103405749A Toad skin transgelin-2-containing anti-tumor traditional Chinese medicine preparation and use thereof
11/27/2013CN103405737A Formula for treatment of osteomyelitis, bone tuberculosis and osteocarcinoma and preparation method
11/27/2013CN103405721A Pharmaceutical composition for inhibiting tumor metastasis and application thereof
11/27/2013CN103405631A Product for patients with lung cancer and preparation method thereof
11/27/2013CN103405605A Traditional Chinese medicine for treating advanced-stage lung cancer, liver cancer, stomach cancer and gynecological cancer
11/27/2013CN103405542A Traditional Chinese medicine for treating leucopenia after chemotherapy
11/27/2013CN103405508A Method for extracting oestrogen active ingredients in cistanche
11/27/2013CN103405497A Preparation method of isodon excisoides total diterpenoid extractive
11/27/2013CN103405480A Conjugate of 10-hydroxycamptothecine-butanedioic acid and adenovirus, as well as production method and use thereof
11/27/2013CN103405459A Application of Chukrasone A in medicaments for treating prostatic carcinoma
11/27/2013CN103405458A Application of Chukrasone A in medicaments for treating hepatocellular carcinoma
11/27/2013CN103405457A Application of Chukrasone A in medicaments for treating skin carcinoma
11/27/2013CN103405456A Applications of Chukrasone A in medicaments for treating leukemia
11/27/2013CN103405455A Application of Chukrasone A in medicaments for treating laryngocarcinoma
11/27/2013CN103405454A Application of Chukrasone A in medicaments for treating renal carcinoma
11/27/2013CN103405453A Application of Chukrasone A in medicaments for treating pancreatic carcinoma
11/27/2013CN103405452A Application of Chukrasone A in medicaments for treating gastric carcinoma
11/27/2013CN103405451A Application of Chukrasone A in medicaments for treating tongue carcinoma
11/27/2013CN103405450A Application of Chukrasone A in medicaments for treating cervical carcinoma
11/27/2013CN103405449A Application of Chukrasone A in medicaments for treating breast carcinoma
11/27/2013CN103405448A Application of Chukrasone A in anti-lung cancer metastasis medicaments
11/27/2013CN103405447A Application of Chukrasone A in medicaments for treating nasopharyngeal carcinoma
11/27/2013CN103405446A Application of Chukrasone A in medicaments for treating bile duct carcinoma
11/27/2013CN103405445A Application of Chukrasone A in medicaments for treating colorectal carcinoma
11/27/2013CN103405444A Application of Chukrasone A in medicaments for treating bladder cancer
11/27/2013CN103405443A Chinese herbal medicine compound taxus chinensis lipidosome preparation for treating breast cancers and preparation method thereof
11/27/2013CN103405437A PI3K small-molecule inhibitor and application thereof
11/27/2013CN103405434A VEGFR-2 (Vascular Endothelial Growth Factor Receptor-2) inhibitor and application thereof
11/27/2013CN103405431A Opioid and opioid-like compounds and uses thereof
11/27/2013CN103405429A VEGFR-2 (Vascular Endothelial Growth Factor Receptor-2) inhibitors and use thereof
11/27/2013CN103405425A Application of Chukrasone B in medicine for treating lung cancer
11/27/2013CN103405424A Application of Chukrasone B in medicine for treating colorectal cancer
11/27/2013CN103405423A Application of Chukrasone B in medicine for treating renal cancer
11/27/2013CN103405422A Application of Chukrasone B in medicine for treating cholangiocarcinoma
11/27/2013CN103405421A Application of Chukrasone B in medicine for treating cervical cancer
11/27/2013CN103405420A Application of Chukrasone B in medicine for treating nasopharynx cancer
11/27/2013CN103405419A Application of Chukrasone B in medicine for treating prostatic cancer
11/27/2013CN103405418A Application of Chukrasone B in medicine for treating breast cancer
11/27/2013CN103405417A Application of Chukrasone B in anti-lung cancer metastasis medicaments
11/27/2013CN103405416A Application of Chukrasone B in medicine for treating endometrial cancer
11/27/2013CN103405415A Application of Chukrasone B in medicine for treating pancreatic cancer
11/27/2013CN103405414A Application of Chukrasone B in medicine for treating ileocecal cancer
11/27/2013CN103405413A Application of Chukrasone B in medicaments for treating bladder cancer
11/27/2013CN103405412A Application of Chukrasone B in medicine for treating laryngocarcinoma
11/27/2013CN103405411A Applications of Chukrasone B in medicaments for treating leukemia
11/27/2013CN103405410A Application of Chukrasone B in medicine for treating gastric cancer
1 ... 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 ... 2211